Lacosamide 10 mg/mL (Lacosamide INJECTION) 10 mg/mL

Lacosamide 10 mg/mL injection is a medication used to manage certain types of seizures. This intravenous solution is formulated for precise dosing and is manufactured by Trigen Laboratories, LLC in the USA.

Strength

10 mg/mL

Pack Size

10 VIAL, GLASS in 1 CARTON (13811-207-40) / 20 mL in 1 VIAL, GLASS (13811-207-74)

Manufacturer / TM Owner

Trigen Laboratories, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lacosamide is primarily used as an adjunctive therapy for the treatment of partial-onset seizures in adults with epilepsy. It works by stabilizing the electrical activity in the brain, which can help reduce the frequency and severity of seizures. This medication is often prescribed when other treatments have not been fully effective.

Side Effects

Common effects of Lacosamide may include dizziness, headache, and nausea. Some individuals might experience fatigue or double vision. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

Lacosamide should be used with caution in individuals with a history of heart conditions or those taking other medications that affect heart rhythm. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

Lacosamide may interact with other medications, including those that affect the central nervous system or heart rhythm. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol should be avoided as it can enhance the sedative effects of Lacosamide.

Frequently Asked Questions

Lacosamide is used as an adjunctive therapy for managing partial-onset seizures in adults with epilepsy.

Lacosamide is administered intravenously, typically in a clinical setting under the supervision of a healthcare professional.

Common side effects may include dizziness, headache, nausea, fatigue, and double vision.

Lacosamide may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Lacosamide should be used with caution in individuals with heart conditions or those taking medications that affect heart rhythm.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.